miRNAs at the heart of the matter.
Cardiovascular disease is among the main causes of morbidity and mortality in developed countries. The pathological process of the heart is associated with altered expression profile of genes that are important for cardiac function. MicroRNAs (miRNAs) have emerged as one of the central players of gene expression regulation. The implications of miRNAs in the pathological process of cardiovascular system have recently been recognized, representing the most rapidly evolving research field. Here, we summarize and analyze the currently available data from our own laboratory and other groups, providing a comprehensive overview of miRNA function in the heart, including a brief introduction of miRNA biology, expression profile of miRNAs in cardiac tissue, role of miRNAs in cardiac hypertrophy and heart failure, the arrhythmogenic potential of miRNAs, the involvement of miRNAs in vascular angiogenesis, and regulation of cardiomyocyte apoptosis by miRNAs. The target genes and signaling pathways linking the miRNAs to cardiovascular disease are highlighted. The applications of miRNA interference technologies for manipulating miRNA expression, stability, and function as new strategies for molecular therapy of human disease are evaluated. Finally, some specific issues related to future directions of the research on miRNAs relevant to cardiovascular disease are pinpointed and speculated.
Wang
Zhiguo
Z
Research Center, Montreal Heart Institute, Montreal, PQ H1T 1C8, Canada. wz.email@gmail.com
Luo
Xioabin
X
Lu
Yanjie
Y
Yang
Baofeng
B
D017209:Apoptosis; D001145:Arrhythmias, Cardiac / Q000378:metabolism; D006332:Cardiomegaly / Q000235:genetics / Q000378:metabolism; D006331:Heart Diseases / Q000235:genetics* / Q000378:metabolism; D006333:Heart Failure / Q000378:metabolism; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism*
D035683:MicroRNAs